Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Ken Baker

Newcastle AuthorsTitleYearFull text
Dr Fiona Rayner
Shaun Hiu
Dr Theophile Bigirumurame
Dr Amy Anderson
Jon Prichard
et al.		Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study2025
Dr Ken Baker
Professor Iain McInnes
Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration2025
Dr Javad Sarvestan
Dr Ken Baker
Dr Silvia Del Din
Exploring the Effect of Sampling Frequency on Real-World Mobility, Sedentary Behaviour, Physical Activity and Sleep Outcomes Measured with Wearable Devices in Rheumatoid Arthritis: Feasibility, Usability and Practical Considerations2025
Mx Nana Aboagye
Maria Germann
Dr Ken Baker
Professor Mark Baker
Dr Silvia Del Din
Feasibility of Predicting Next-Day Fatigue Levels Using Heart Rate Variability and Activity-Sleep Metrics in People with Post-COVID Fatigue.2025
Dr Leher Gumber
Dr Fiona Rayner
Dr Theophile Bigirumurame
Dr Bernard Dyke
Sean Kerrigan
et al.		Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis2025
Mx Nana Aboagye
Dr Chloe Hinchliffe
Professor Fai Ng
Dr Silvia Del Din
Dr Ken Baker
et al.		Systematic Review: Digital Biomarkers of Fatigue in Chronic Diseases2025
Dr Ken Baker
Dr David McDonald
Dr Gill Hulme
Raf Hussain
Dr Jonathan Coxhead
et al.		Single-cell insights into immune dysregulation in rheumatoid arthritis flare versus drug-free remission2024
Dr Domenico Somma
Professor John Isaacs
Professor Andrew Filby
Dr David McDonald
Dr Jasmine Sim
et al.		Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis2024
Alice Lin
Dr Josh Bennett
Dr Ewan Hunter
Dr Alice Lorenzi
Dr Bridget Griffiths
et al.		COVID-19 antiviral therapy for non-hospitalised immunosuppressed patients with rheumatic diseases is feasible with positive outcomes2023
Emily Hunter
Professor Anthony De Soyza
Dr Rachel Agbeko
Dr Ken Baker
Dr Quentin Campbell Hewson
et al.		Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial2022
Dr Nikolaos Vlachogiannis
Dr Ken Baker
Dr Georgios Georgiopoulos
Dr Ina Schim van der Loeff
Dr Aidan Hanrath
et al.		Clinical frailty, and not features of acute infection, is associated with late mortality in COVID-19: a retrospective cohort study2022
Dr Ken Baker
Dr Dennis Lendrem
Adam Scadeng
Dr Ben Thompson
Dr Arthur Pratt
et al.		Erratum to "Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study" [J. Autoimmun. 105 (December 2019) 1022982022
Dr Ken Baker
Dr Christopher Duncan
Dr Suzanne Elcombe
Professor Andrew Gennery
Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK2022
Dr Fiona Rayner
Dr Amy Anderson
Dr Ken Baker
Professor Christopher Buckley
Dr Bernard Dyke
et al.		BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study2021
Dr Ken Baker
JASMINE Sim Por Xin
Professor John Isaacs
Biomarkers of tolerance in immune-mediated inflammatory diseases: a new era in clinical management?2021
123